[Triptans in migraine: from clinical view].
Manaka
Shinya
S
Manaka Hospital, Kanagawa, Japan.
D004334:Drug Administration Schedule; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D008881:Migraine Disorders / Q000188:drug therapy* / Q000378:metabolism; D023303:Oxazolidinones / Q000627:therapeutic use; D011759:Pyrrolidines / Q000627:therapeutic use; D044346:Receptor, Serotonin, 5-HT1D; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D018170:Sumatriptan / Q000627:therapeutic use; D014363:Tryptamines
D007211:Indoles; D023303:Oxazolidinones; D011759:Pyrrolidines; D044346:Receptor, Serotonin, 5-HT1D; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; C115647:eletriptan; C089750:zolmitriptan; D018170:Sumatriptan